Life Insurance Nepal (XNEP:LICN) Research & Development: NPR0 Mil (TTM As of Apr. 2026)


XNEP:LICN Life Insurance Corp Nepal Ltd XNEP:LICN
82 GF Score
Price NPR777.40
GF Value NPR890.40
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Life Insurance Nepal Research & Development?

Life Insurance Nepal XNEP:LICN -1.59% 82 Research & Development is NPR0 Mil as of Apr. 2026. GuruFocus rates XNEP:LICN with a GF Score™ of 82/100 and a GF Value™ of NPR890.40 (Modestly Undervalued). The stock has 4 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Life Insurance Nepal's Research & Development for the three months ended in Apr. 2026 was NPR0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Apr. 2026 was NPR0 Mil.

Life Insurance Nepal  (XNEP:LICN) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Life Insurance Nepal Research & Development Related Terms

Life Insurance Nepal Research & Development Historical Data

* Premium members only.

The historical data trend for Life Insurance Nepal's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Life Insurance Nepal Research & Development Chart

Life Insurance Nepal Annual Data
Trend Jul16 Jul17 Jul18 Jul19 Jul20 Jul21 Jul22 Jul23 Jul24 Jul25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Life Insurance Nepal Quarterly Data
Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26 Apr26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
XNEP:LICN
82GF Score
Life Insurance Corp Nepal Ltd XNEP:LICN
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Life Insurance Nepal Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Apr. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was NPR0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of NPR0 Mil mean?
Life Insurance Nepal (XNEP:LICN) has a Research & Development of NPR0 Mil as of Apr. 2026. Research and development expense is the total cost for research and development activities. View historical data on Life Insurance Nepal and its competitors.
Is Life Insurance Nepal's Research & Development too high?
Life Insurance Nepal's current Research & Development is NPR0 Mil. Overall, Life Insurance Nepal has a GF Score™ of 82/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Life Insurance Nepal's Research & Development compare to AFL and MET?
Life Insurance Nepal's Research & Development of NPR0 Mil can be compared against companies in the Insurance industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for an Insurance company?
A good Research & Development depends on the Insurance industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Life Insurance Nepal and its competitors. Life Insurance Nepal's current Research & Development is NPR0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Life Insurance Nepal stock overvalued right now?
Based on GuruFocus' analysis, Life Insurance Nepal (XNEP:LICN) is currently considered Modestly Undervalued. The stock's GF Value™ is NPR890.40, compared to a current price of NPR777.40 — trading 12.7% below its estimated fair value. The current Research & Development is NPR0 Mil. Life Insurance Nepal's overall GF Score™ is 82/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Life Insurance Nepal (XNEP:LICN), the current Research & Development is NPR0 Mil as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Life Insurance Nepal (XNEP:LICN) Overvalued in 2026?

Based on GuruFocus' analysis, Life Insurance Nepal stock appears to be undervalued. The current stock price of NPR777.40 is trading 12.7% below its estimated GF Value™ of NPR890.40. GuruFocus considers Life Insurance Nepal to be Modestly Undervalued.

Key valuation signals for XNEP:LICN:

  • Research & Development: NPR0 Mil
  • GF Value™: NPR890.40 vs. price of NPR777.40 (12.7% below fair value)
  • GF Score™: 82/100 with 4 warning signs

No single metric tells the full story. See the XNEP:LICN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Life Insurance Nepal Business Description

Address Star Mall, PO Box No 21905, 4th Floor, Putalisadak, Kathmandu, NPL
Life Insurance Corp Nepal Ltd is engaged in the life insurance business in Nepal, providing participating and non-participating life insurance products through its provincial offices, branches, sub-branches, and network of agents. Its product portfolio includes endowment plans, child plans, and money-back plans, and it provides services such as reviving lapsed policies, policy loans, nominations, and bonuses to policyholders. Revenue is mainly generated from premiums and investments, including regular and single-premium collections, returns from investments in equities, bonds, and other financial instruments, service-related fees, and commission on reinsurance ceded.
82GF Score

Get the complete analysis for XNEP:LICN

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NPR777.40
Price
NPR890.40
GF Value